{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:32:19Z","timestamp":1791844339662,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"vor","delay-in-days":378,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.chom.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:16:41Z","timestamp":1431562601000},"page":"653-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection"],"prefix":"10.1016","volume":"17","author":[{"given":"Cherie\u00a0T.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian\u00a0M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John\u00a0R.","family":"Teijaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew\u00a0M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen\u00a0C.F.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert\u00a0D.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0B.A.","family":"Oldstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2015.04.005_bib1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1084\/jem.167.5.1719","article-title":"Organ-specific selection of viral variants during chronic infection","volume":"167","author":"Ahmed","year":"1988","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chom.2015.04.005_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","article-title":"Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence","volume":"160","author":"Ahmed","year":"1984","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chom.2015.04.005_bib3","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1073\/pnas.1408148111","article-title":"Type I interferon is a therapeutic target for virus-induced lethal vascular damage","volume":"111","author":"Baccala","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.chom.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/viro.1999.9811","article-title":"Lymphotoxin-beta-deficient mice show defective antiviral immunity","volume":"260","author":"Berger","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.chom.2015.04.005_bib6","doi-asserted-by":"crossref","first-page":"21641","DOI":"10.1073\/pnas.1011998107","article-title":"Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression","volume":"107","author":"Bergthaler","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/jir.2012.0037","article-title":"The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response","volume":"33","author":"Bolen","year":"2013","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.chom.2015.04.005_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/JVI.69.2.1059-1070.1995","article-title":"Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression","volume":"69","author":"Borrow","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2015.04.005_bib9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in\u00a0vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2015.04.005_bib10","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1073\/pnas.0811139106","article-title":"IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection","volume":"105","author":"Brooks","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ana.10084","article-title":"Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production","volume":"51","author":"Byrnes","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chom.2015.04.005_bib12","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/ncomms4864","article-title":"Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection","volume":"5","author":"Davidson","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2015.04.005_bib13","doi-asserted-by":"crossref","first-page":"e56527","DOI":"10.1371\/journal.pone.0056527","article-title":"Interferon-\u03b1 is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers","volume":"8","author":"Hardy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.chom.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1128\/JVI.02612-09","article-title":"Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques","volume":"84","author":"Harris","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00330-004-2543-6","article-title":"Assessment of right ventricular function by 16-detector-row CT: comparison with magnetic resonance imaging","volume":"15","author":"Koch","year":"2005","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.chom.2015.04.005_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.virol.2013.04.010","article-title":"Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp\/LCMV chimeric virus","volume":"442","author":"Lee","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.chom.2015.04.005_bib18","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1128\/JVI.00555-06","article-title":"Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus","volume":"80","author":"Mart\u00ednez-Sobrido","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2015.04.005_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chom.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/IAI.00810-10","article-title":"Beta interferon suppresses the development of experimental cerebral malaria","volume":"79","author":"Morrell","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2015.04.005_bib21","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T\u00a0cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/jvi.76.5.2375-2383.2002","article-title":"Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production","volume":"76","author":"M\u00fcller","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"14116","DOI":"10.1073\/pnas.1211910109","article-title":"Infected CD8\u03b1- dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection","volume":"109","author":"Ng","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib24","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1073\/pnas.88.18.8252","article-title":"Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure","volume":"88","author":"Odermatt","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib25","first-page":"83","article-title":"Biology and pathogenesis of lymphocytic choriomeningitis virus infection","volume":"263","author":"Oldstone","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.chom.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2010.11.023","article-title":"Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response","volume":"411","author":"Oldstone","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.chom.2015.04.005_bib27","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1073\/pnas.1401662111","article-title":"Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection","volume":"111","author":"Osokine","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imr.12001","article-title":"Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation","volume":"250","author":"Piehler","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.chom.2015.04.005_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.chom.2011.02.006","article-title":"Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner","volume":"9","author":"Popkin","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2015.04.005_bib30","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/eji.201142275","article-title":"Antigen amount dictates CD8+ T-cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell","volume":"42","author":"Richter","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.chom.2015.04.005_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410400412","article-title":"Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis","volume":"40","author":"Rudick","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chom.2015.04.005_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2011.05.003","article-title":"Emerging Tim-3 functions in antimicrobial and tumor immunity","volume":"32","author":"Sakuishi","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.chom.2015.04.005_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chom.2015.04.005_bib34","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JVI.02228-07","article-title":"Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics","volume":"82","author":"Sedaghat","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2015.04.005_bib35","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.192.9.1249","article-title":"Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells","volume":"192","author":"Sevilla","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chom.2015.04.005_bib36","first-page":"125","article-title":"Infection of dendritic cells by lymphocytic choriomeningitis virus","volume":"276","author":"Sevilla","year":"2003","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.chom.2015.04.005_bib37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/jir.2006.26.804","article-title":"Blocking monoclonal antibodies specific for mouse IFN-alpha\/beta receptor subunit 1 (IFNAR-1) from mice immunized by in\u00a0vivo hydrodynamic transfection","volume":"26","author":"Sheehan","year":"2006","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.chom.2015.04.005_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2249.2000.01144.x","article-title":"Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection","volume":"119","author":"Stylianou","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.chom.2015.04.005_bib39","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1073\/pnas.1019304108","article-title":"Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence","volume":"108","author":"Sullivan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2015.04.005_bib40","doi-asserted-by":"crossref","first-page":"e1004588","DOI":"10.1371\/journal.ppat.1004588","article-title":"Early virus-host interactions dictate the course of a persistent infection","volume":"11","author":"Sullivan","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2015.04.005_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.chom.2015.04.005_bib42","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.1233665","article-title":"Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses","volume":"339","author":"Teles","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.chom.2015.04.005_bib43","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.45.7.1277","article-title":"Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial","volume":"45","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.chom.2015.04.005_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cell.2011.06.048","article-title":"Structural linkage between ligand discrimination and receptor activation by type I interferons","volume":"146","author":"Thomas","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.chom.2015.04.005_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/viro.1993.1389","article-title":"Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect","volume":"195","author":"Tishon","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.chom.2015.04.005_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T\u00a0cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chom.2015.04.005_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T\u00a0cell exhaustion and chronic viral infection","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2015.04.005_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.chom.2015.04.005_bib49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T\u00a0cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2015.04.005_bib50","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1212\/WNL.51.3.682","article-title":"Interferon beta in the treatment of multiple sclerosis: mechanisms of action","volume":"51","author":"Yong","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.chom.2015.04.005_bib51","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI45157","article-title":"Cumulative mechanisms of lymphoid tissue fibrosis and T\u00a0cell depletion in HIV-1 and SIV infections","volume":"121","author":"Zeng","year":"2011","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312815001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312815001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T04:41:26Z","timestamp":1599021686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312815001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1931312815001638"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2015.04.005","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}